Literature DB >> 2298462

Human non-lineage antigen, CD46 (HuLy-m5): purification and partial sequencing demonstrates structural homology with complement-regulating glycoproteins.

D F Purcell1, N J Deacon, S M Andrew, I F McKenzie.   

Abstract

CD46, until recently known as HuLy-m5, is a non-lineage restricted surface antigen ubiquitously expressed by almost all human cells except erythrocytes. The CD46 antigen is identified by the E4.3 monoclonal antibody (mAb) and exists at the surface of human peripheral blood lymphocytes (PBLs) as two acidic, non-disulfide bonded chains, alpha and beta, of Mr 66,000 and 56,000. Receptor density analysis showed that CD46 was of moderately low abundance on PBLs with 7.5 x 10(3) molecules present on each cell. The two chains of CD46 were purified (144,000-fold) by immunoaffinity-chromatography with E4.3 mAb from the plasma membranes of a human spleen infiltrated with chronic myelogenous leukemia cells. Amino acid sequence analysis of the NH2-terminal of both alpha and beta chains yielded the same sequence; XEEPPQ/TFEAMELIGKPKPYYEIGE. Peptide mapping studies confirmed that both CD46 chains were closely related, except for one peptide fragment. This amino acid sequence is identical to that of the NH2-terminal of the recently cloned membrane co-factor protein (MCP), a membrane protein that binds the C3b and C4b fragments of complement and acts as a co-factor for I protein-mediated decay of the complement convertases. CD46 shares a cross-reactive epitope with some primate retroviruses, and this may indicate that some retroviruses mimic the mechanisms used by autologous human cells to evade complement-mediated immune clearance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298462     DOI: 10.1007/bf00702485

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  13 in total

1.  The amino-terminal sequences of Ly-2 and Ly-3.

Authors:  I D Walker; B J Murray; L Kirszbaum; G W Chambers; N J Deacon; I F McKenzie
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

3.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

Review 4.  Human endogenous retroviruses.

Authors:  M Cohen; E Larsson
Journal:  Bioessays       Date:  1988-12       Impact factor: 4.345

5.  Hu Ly-m5: a unique antigen physically associated with HLA molecules.

Authors:  R L Sparrow; I F McKenzie
Journal:  Hum Immunol       Date:  1983-05       Impact factor: 2.850

6.  A gas-liquid solid phase peptide and protein sequenator.

Authors:  R M Hewick; M W Hunkapiller; L E Hood; W J Dreyer
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

7.  Cross-reactivity of a normal human cell surface antigen with primate retrovirus glycoproteins.

Authors:  R L Sparrow; D F Purcell; I F McKenzie
Journal:  Hum Immunol       Date:  1985-06       Impact factor: 2.850

8.  Organization of the genes encoding complement receptors type 1 and 2, decay-accelerating factor, and C4-binding protein in the RCA locus on human chromosome 1.

Authors:  M C Carroll; E M Alicot; P J Katzman; L B Klickstein; J A Smith; D T Fearon
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

9.  Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Authors:  T Seya; J R Turner; J P Atkinson
Journal:  J Exp Med       Date:  1986-04-01       Impact factor: 14.307

10.  Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins.

Authors:  D M Lublin; M K Liszewski; T W Post; M A Arce; M M Le Beau; M B Rebentisch; L S Lemons; T Seya; J P Atkinson
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Pancreatic ductal adenocarcinoma: a review of immunologic aspects.

Authors:  Megan B Wachsmann; Laurentiu M Pop; Ellen S Vitetta
Journal:  J Investig Med       Date:  2012-04       Impact factor: 2.895

2.  Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation.

Authors:  D F Purcell; S M Russell; N J Deacon; M A Brown; D J Hooker; I F McKenzie
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.